seed
Stage
1
Investors
About
Karma Biotechnologies develops engineered cytokine therapeutics aimed at improving the efficacy and safety of immunotherapies for cancer and autoimmune diseases.
Explore Karma Biotechnologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.